|
||
Brief Definitive Reports |
Correspondence to: Shimon Sakaguchi, Dept. of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Tel:81-75-751-3888 Fax:81-75-751-3820 E-mail:shimon{at}frontier.kyoto-u.ac.jp.
This report shows that cytotoxic T lymphocyteassociated antigen 4 (CTLA-4) plays a key role in T cellmediated dominant immunologic self-tolerance. In vivo blockade of CTLA-4 for a limited period in normal mice leads to spontaneous development of chronic organ-specific autoimmune diseases, which are immunopathologically similar to human counterparts. In normal naive mice, CTLA-4 is constitutively expressed on CD25+CD4+ T cells, which constitute 510% of peripheral CD4+ T cells. When the CD25+CD4+ T cells are stimulated via the T cell receptor in vitro, they potently suppress antigen-specific and polyclonal activation and proliferation of other T cells, including CTLA-4deficient T cells, and blockade of CTLA-4 abrogates the suppression. CD28-deficient CD25+CD4+ T cells can also suppress normal T cells, indicating that CD28 is dispensable for activation of the regulatory T cells. Thus, the CD25+CD4+ regulatory T cell population engaged in dominant self-tolerance may require CTLA-4 but not CD28 as a costimulatory molecule for its functional activation. Furthermore, interference with this role of CTLA-4 suffices to elicit autoimmune disease in otherwise normal animals, presumably through affecting CD25+CD4+ T cellmediated control of self-reactive T cells. This unique function of CTLA-4 could be exploited to potentiate T cellmediated immunoregulation, and thereby to induce immunologic tolerance or to control autoimmunity.
Key Words: CTLA-4, autoimmune disease, regulatory T cell, CD25, self-tolerance
This article has been cited by other articles:
| TABLE OF CONTENTS |
|